After US approval, Japan OKs Leqembi, its first Alzheimer's drug, developed by Eisai and Biogen

After US approval, Japan OKs Leqembi, its first Alzheimer's drug, developed by Eisai and Biogen

Upworthy

Published

Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies. It's the first drug for treatment of the disease in a country with a rapidly aging population. Developed by Japanese drugmaker Eisai Co. and U.S.…

#leqembi #eisaico #biogeninc #fumiokishida #healthministry #eisai #kyodonews #haruonaito

Full Article